Improving access to HIV prevention for rural people who inject drugs
Optimizing PrEP Care Delivery through Adaptive Intervention Strategies for Underserved Rural People who Inject Drugs
['FUNDING_R01'] · UNIVERSITY OF KENTUCKY · NIH-11037395
This study is all about finding better ways to help people who inject drugs in rural areas get and stay on PrEP, a medication that helps prevent HIV, by offering personalized support and care.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KENTUCKY (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-11037395 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the delivery of Pre-Exposure Prophylaxis (PrEP) care to underserved rural populations, particularly people who inject drugs (PWID). It aims to address barriers to PrEP uptake through adaptive intervention strategies, building on previous successful pilot interventions in Kentucky's Appalachian region. The study will implement and evaluate new approaches to increase the number of PWID who initiate and continue PrEP, thereby reducing the risk of HIV transmission. Participants will receive support through case management and tailored interventions designed to meet their specific needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in rural areas who inject drugs and are at risk for HIV.
Not a fit: Patients who do not inject drugs or those who are already engaged in effective HIV prevention strategies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase PrEP uptake among rural PWID, leading to a reduction in new HIV infections.
How similar studies have performed: Previous pilot interventions in this region have shown promising results in improving PrEP care delivery for PWID, indicating a potential for success with these new strategies.
Where this research is happening
LEXINGTON, UNITED STATES
- UNIVERSITY OF KENTUCKY — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SURRATT, HILARY L — UNIVERSITY OF KENTUCKY
- Study coordinator: SURRATT, HILARY L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus